279 related articles for article (PubMed ID: 17825750)
1. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
Maahs DM; Snell-Bergeon JK; Kinney GL; Wadwa RP; Garg S; Ogden LG; Rewers M
J Diabetes Complications; 2007; 21(5):273-9. PubMed ID: 17825750
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.
Wadwa RP; Kinney GL; Ogden L; Snell-Bergeon JK; Maahs DM; Cornell E; Tracy RP; Rewers M
Int J Biochem Cell Biol; 2006; 38(5-6):996-1003. PubMed ID: 16271309
[TBL] [Abstract][Full Text] [Related]
3. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
[TBL] [Abstract][Full Text] [Related]
4. Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study.
Johnson SL; Tierney EF; Onyemere KU; Tseng CW; Safford MM; Karter AJ; Ferrara A; Duru OK; Brown AF; Narayan KM; Thompson TJ; Herman WH
Diabetes Care; 2006 Aug; 29(8):1733-8. PubMed ID: 16873772
[TBL] [Abstract][Full Text] [Related]
5. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
Imaizumi S; Miura S; Nishikawa H; Iwata A; Zhang B; Kawamura A; Tsuchiya Y; Kumagai K; Matsuo K; Saku K
Hypertens Res; 2006 Mar; 29(3):135-41. PubMed ID: 16755148
[TBL] [Abstract][Full Text] [Related]
7. Low plasma adiponectin levels predict progression of coronary artery calcification.
Maahs DM; Ogden LG; Kinney GL; Wadwa P; Snell-Bergeon JK; Dabelea D; Hokanson JE; Ehrlich J; Eckel RH; Rewers M
Circulation; 2005 Feb; 111(6):747-53. PubMed ID: 15699257
[TBL] [Abstract][Full Text] [Related]
8. Lower-extremity arterial calcification as a correlate of coronary artery calcification.
Costacou T; Huskey ND; Edmundowicz D; Stolk R; Orchard TJ
Metabolism; 2006 Dec; 55(12):1689-96. PubMed ID: 17142145
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis.
Kretowski A; McFann K; Hokanson JE; Maahs D; Kinney G; Snell-Bergeon JK; Wadwa RP; Eckel RH; Ogden L; Garg S; Li J; Cheng S; Erlich HA; Rewers M
Diabetes; 2007 Mar; 56(3):863-71. PubMed ID: 17327458
[TBL] [Abstract][Full Text] [Related]
10. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
Sjølie AK; Chaturvedi N; Fuller J
Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
[TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibitors and calcium channel blockers: patterns of use and associations with mortality in type 1 diabetes.
Sobolewski BA; Zgibor JC; Orchard TJ
Diabetes Res Clin Pract; 2004 Jul; 65(1):37-43. PubMed ID: 15163476
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 is associated with coronary artery calcium in Type 1 diabetes.
Pratte KA; Barón AE; Ogden LG; Hassell KL; Rewers M; Hokanson JE
J Diabetes Complications; 2009; 23(6):387-93. PubMed ID: 18768333
[TBL] [Abstract][Full Text] [Related]
14. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
Chuahirun T; Khanna A; Kimball K; Wesson DE
Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA).
Kronmal RA; McClelland RL; Detrano R; Shea S; Lima JA; Cushman M; Bild DE; Burke GL
Circulation; 2007 May; 115(21):2722-30. PubMed ID: 17502571
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
Formica RN; Friedman AL; Lorber MI; Bia MJ
Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
[TBL] [Abstract][Full Text] [Related]
19. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
